摘要
目的探讨髂内动脉灌注化疗前后P53、bcl-2、血管内皮生长因子(VEGF)在浸润性膀胱肿瘤组织中表达的意义。方法采用免疫组化法对8例浸润性膀胱肿瘤患者动脉灌注化疗前后血清中的P53、bcl-2、VEGF进行检测。结果灌注前P53的表达率为50%(+~++),bcl-2的表达率为50%(+~+++),VEGF的表达率为50%(+~++);灌注后P53的表达率为50%(+~++),bcl-2为阴性,VEGF的表达率为50%(+)。结论灌注化疗能降低肿瘤标记物的表达,检测P53、bcl-2、VEGF对肿瘤治疗的有效性和预后判断有重要意义。
Objective To investigate the significance of expression of P53?bcl-2 and VEGF in patient with invasive bladder tumor before and after Intra-arterial chemotherapy. Methods 8 cases of bladder tumors were detected by immunohitochemistry technique on P53?bcl-2 and VEGF before and after Intra-arterial chemotherapy. Results Before Intra-arterial chemotherapy, the expression rate of P53, bcl-2 and VEGF were all 50%; after Intra-arterial chemotherapy, P53 was 50%, bcl-2 was negative and VEGF was 50%. Conclusions Intra-arterial chemotherapy can reduce the expression of tumor markers, it may play an important role in effective therapy of invasive bladder cancer and the evaluation of prognosis.
出处
《北京医学》
CAS
2005年第4期222-224,共3页
Beijing Medical Journal
关键词
膀胱肿瘤
肿瘤标记物
免疫组化
灌注化疗
Bladder tumor Tumor markers Immunohistochemistry Intra-arterial chemotherapy